|Mar-Apr '03 | briefing | mail | don't say this | flakers' jargon | flaker creativity | articles | other places | archives | send mail | ed dewke | legal stuff | order | search | ©2001 Ed Dewke|
the Cost of the New Wonder Drugs
Well Ed, as you
know by now Amevive was approved for use by the FDA. According to what I
have read tonight it will be acceptable for the Derms to order it for
their office delivery or to a pharmacy according to their patients’
insurance dictums on Monday (02-03-03). Now the big quandary is do we seek
out this new biologic or wait for Raptiva?
It sure is nice to have Enbrel, Amevive, and possibly Raptiva to
worry about. My greatest concern is that there are far too many of us who
can not afford any of these options.
I may be very
mistaken, but I consider the U.S.A. to be one of the wealthiest nations on
the planet — if not the
wealthiest. We have seniors who can not afford life sustaining drugs and
people like us in that same boat.
I could go on
about drug company compensations (yes, I do understand R&D) but I'm
not going to convince anyone that we need to tweak our system. All of this
insurance rhetoric comes from me — the wife of a former Insurance
Company President, CFO, Casualty Actuary, Senior VP of a major insurance
company and an insurance agent. So I know from whence I speak.
I will be able
to make my choices but, what about the rest of us? I don't expect you to
have the answers. I just get exasperated and need to vent. Thanks for
Response: I, too, am concerned
about the high cost of these new drugs.
I was unable to find any pricing for Amevive and am still unsure
how most people will take it. What
I’ve read says it requires (initially) a 12 week course of one dose per
week, administered intravenously (IV) or
through intramuscular injection. Some
people may get the IM injections at home, but most will probably go to the
doctor for their shots or infusions. This
can’t be cheap. In addition
to the drug, you’ll pay something for the office visit.
another biologic approved last year — costs about $150 a dose, which is
self-administered through a subcutaneous injection, two doses a week for
the duration of the therapy (no max duration, as far as I know).
So far, I’ve
received mostly glowing reports from other Enbrel users regarding
co-operation from their insurers. Some,
like me, had to go a few rounds, but no one who’s written in has
reported being denied coverage for Enbrel.
We can only hope it goes so well for Amevive.
As you probably
know, some kind of improved prescription availability program is under
“discussion” in Washington, D.C. President
Bush has mentioned it in several contexts.
We flakers are, relatively speaking, a small contingent in the
overall problem of health care disparities, but surely the new
availability of these high-priced drugs for our chronic condition can only
serve to underscore the difference between the haves and have nots within
Like you, Jordan, my voice doesn’t count for much in this milieu, either. Thanks for giving me an opportunity to vent alongside you. -Ed